| JXSL2101055 | 帕博利珠单抗注射液 | pembrolizumab | Injection | Biological Products(2.2) | Import Drug Application | 2021-07-08 | | Merck Sharp & Dohme Corp;MSD R&D (China) Co Ltd | | | view |
| JTS2500009 | 帕博利珠单抗注射液（皮下注射） | pembrolizumab | Injection | Biological Products | Disposable Import Drug Application | 2025-01-25 | | BSP Pharmaceuticals Srl;MSD R&D (China) Co Ltd;Merck Sharp & Dohme BV | | | view |
| JXSB2200056 | 帕博利珠单抗注射液 | pembrolizumab | Injection | Biological Products(2.2) | Supplementary Application | 2022-05-07 | | Msd Ireland;Merck Sharp & Dohme Corp | | | view |
| JXSL2101109 | 帕博利珠单抗注射液 | pembrolizumab | Injection | Biological Products(2.2) | Import Drug Application | 2021-09-14 | | Merck Sharp & Dohme Corp;MSD R&D (China) Co Ltd | | | view |
| JXSB2101016 | 帕博利珠单抗注射液 | pembrolizumab | Injection | Biological Products(2.2) | Supplementary Application | 2021-06-02 | | Msd Ireland;Merck Sharp & Dohme Corp | | | view |
| JXSS2300028 | 帕博利珠单抗注射液 | pembrolizumab | Injection | Biological Products(2.2) | Import Drug Application | 2023-03-29 | | Msd Ireland;Merck Sharp & Dohme Ltd;MSD R&D (China) Co Ltd | | | view |
| JTS2400017 | favezelimab帕博利珠单抗注射液 | favezelimab;pembrolizumab | Injection | Biological Products | Disposable Import Drug Application | 2024-03-12 | | Msd Ireland;Merck Sharp & Dohme Ltd;MSD R&D (China) Co Ltd | | | view |
| JXSB2200136 | 帕博利珠单抗注射液 | pembrolizumab | Injection | Biological Products | Supplementary Application | 2022-10-22 | | Msd Ireland;Merck Sharp & Dohme Ltd | | | view |
| JYSB2300201 | 帕博利珠单抗注射液 | pembrolizumab | Injection | Biological Products(3.1) | Supplementary Application | 2023-12-01 | | Msd Ireland;Merck Sharp & Dohme Ltd | | | view |
| JYSB2101099 | 帕博利珠单抗注射液 | pembrolizumab | Injection | Biological Products | Supplementary Application | 2021-08-10 | | Msd Ireland;Merck Sharp & Dohme Corp | | | view |
| JYSB2300100 | 帕博利珠单抗注射液 | pembrolizumab | Injection | Biological Products | Supplementary Application | 2023-05-25 | | Msd Ireland;Merck Sharp & Dohme Corp | | | view |
| JXSL2400084 | 帕博利珠单抗注射液 | pembrolizumab | Injection | Biological Products(2.2) | Import Drug Application | 2024-05-01 | | Merck Sharp & Dohme Ltd;MSD R&D (China) Co Ltd | | | view |
| JXSL2200134 | 帕博利珠单抗注射液 | pembrolizumab | Injection | Biological Products(2.2) | Import Drug Application | 2022-08-23 | | Merck Sharp & Dohme Corp;MSD R&D (China) Co Ltd | | | view |
| JXSL2400023 | 帕博利珠单抗注射液 | pembrolizumab | Injection | Biological Products(2.2) | Import Drug Application | 2024-01-24 | | Merck Sharp & Dohme Ltd;MSD R&D (China) Co Ltd | | | view |
| JXSB2101007 | 帕博利珠单抗注射液 | pembrolizumab | Injection | Biological Products | Supplementary Application | 2021-05-08 | | Merck Sharp & Dohme Corp;Msd Ireland | | | view |
| JXSB2101047 | 帕博利珠单抗注射液 | pembrolizumab | Injection | Biological Products | Supplementary Application | 2021-08-19 | | Merck Sharp & Dohme Corp;Msd Ireland | | | view |
| JXSB2300113 | 帕博利珠单抗注射液 | pembrolizumab | Injection | Biological Products(2.2) | Supplementary Application | 2023-09-16 | | Msd Ireland;Merck Sharp & Dohme Ltd | | | view |
| JXSS2400071 | 帕博利珠单抗注射液 | pembrolizumab | Injection | Biological Products(2.2) | Import Drug Application | 2024-09-04 | | Msd Ireland;Merck Sharp & Dohme Ltd;MSD R&D (China) Co Ltd | | | view |
| JYSB2200007 | 帕博利珠单抗注射液 | pembrolizumab | Injection | Biological Products | Supplementary Application | 2022-01-13 | | Msd Ireland;Merck Sharp & Dohme Corp | | | view |
| JXSL2101007 | 帕博利珠单抗注射液 | pembrolizumab | Injection | Biological Products(2.2) | Import Drug Application | 2021-04-12 | | Merck Sharp & Dohme Corp;MSD R&D (China) Co Ltd | | | view |
